Richtech Robotics (NASDAQ:RR), a company that specializes in developing, manufacturing, and deploying robotic solutions for ...

BROADEN2 Phase 2b trial in atopic dermatitis (AD) ongoing, with data expected by mid-2027KT-621 BREADTH Phase 2b trial in asthma ...

This afternoon, we released financial results for the quarter and full year ended December 31, 2025, and recent corporate updates. The press release is available on the Investors section of our ...

Hello, ladies and gentlemen. Thank you for standing by, and welcome to Zai Lab's Fourth Quarter and Full Year 2025 Financial Results Conference Call. [Operator Instructions] As a reminder, today's ...

BAE Systems plc (OTC:BAESY) Q4 2025 Earnings Call Transcript February 18, 2026 BAE Systems plc misses on earnings expectations. Reported EPS is $2.13 EPS, expectations were $2.21. Operator: Good day, ...

WEIFANG, SHANDONG, CHINA, January 29, 2026 /EINPresswire.com/ -- The global industrial landscape relies heavily on the ...

Secured $26 Million in PIPE Financing Led by a Top-Tier Biotech Investor to Advance Preclinical Programs and Extend Cash RunwayProgressed ...

Master's Union, a Gurgaon-based institution founded in 2020 seen as an alternative to the Indian Institutes of Management, could soon become a state private university as Haryana government tightens ...

The journey towards circular high-performance composites begins with one core question: why redesign an already mature class of materials? To set the scene, we asked the consortium to describe the ...

Fellow shareholders, Axon completed another record year in pursuit of our mission to protect life. Revenue grew 33% year over year, marking our fourth consecutive year of annual g ...

Global-e Online Ltd. (NASDAQ:GLBE) Q4 2025 Earnings Call Transcript February 18, 2026 Global-e Online Ltd. beats earnings expectations. Reported EPS is $0.35, expectations were $0.3. Operator: Good ...

Detailed price information for Medicenna Therapeutics Corp (MDNA-T) from The Globe and Mail including charting and trades.